29 Sep. 2020
Mexico City selects patients for COVID-19 treatment trials
On Friday, Mexico City’s Health Ministry began the process to select 360 patients with COVID-19 that will participate in the clinical trials for the drugs Camostat Mesylate and Artemisia Annua at the Tlalpan, Tláhuac, Iztapalapa, and Iztacalco boroughs.
Read the article
Recent News
12 Mar. 2024
